iRhythm Holdings (IRTC) Net Income Growth (3y) (2018 - 2026)

iRhythm Holdings (IRTC) Net Income Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -6.51%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 7.96%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.93%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 62.29%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 60.12%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.38%
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 280.49%
10 iRhythm Holdings 3.65 Bn 3.10 Bn 141.35 Mn 29.11%

Historic Data

Download Data
DateValue
Mar 31, 2026 29.11%
Dec 31, 2025 31.54%
Sep 30, 2025 37.60%
Jun 30, 2025 15.89%
Mar 31, 2025 15.35%
Dec 31, 2024 65.51%
Sep 30, 2024 -24.85%
Jun 30, 2024 -5.02%
Mar 31, 2024 -18.02%
Dec 31, 2023 -58.87%
Sep 30, 2023 -79.65%
Jun 30, 2023 3.30%
Mar 31, 2023 -62.79%
Dec 31, 2022 -5.30%
Sep 30, 2022 -5.45%
Jun 30, 2022 -30.61%
Mar 31, 2022 -83.06%
Dec 31, 2021 -25.93%
Sep 30, 2021 -34.62%
Jun 30, 2021 -12.46%